|
Amag Pharmaceuticals ( AMAG) Stock PriceCompany Description : A biopharmaceutical company that utilizes its proprietary technology for the development and commercialization of a therapeutic iron compound to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease. url: www.amagpharma.com |
Name:
Amag Pharmaceuticals, Inc. (MM) |
Symbol:
NASDAQ:AMAG |
Stock Market:
NASDAQ |
Type:
Common Stock |
ISIN:
US00163U1060 |
Description:
|
| | Change | Change % | Cur | Bid | Ask | High | Low | Open | Volume | Time | A | |  | -0.02 | -0.15 | 13.12 | 13.08 | 13.18 | 13.27 | 12.9 | 13.13 | 14356 | 10:27:45 | | |
AMAG Pharmaceuticals Appoints William Heiden as President and Chief Executive Officer
AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced the appointment of William K. Heiden as president and chief executive officer, effective May 14, 2012. Mr. Heiden, age 52, has also been appointed to the company’s board of directors. AMAG also announced that its largest shareholder, Adage Capital, has requested... Amag Pharmaceuticals News & Message Board DiscussionAmag Pharmaceuticals Company Information| Sector | Turnover (m) | Profit (m) | EPS - Basic | PE ratio | Mkt Cap (m) | NMS | | | 0.00 | 0.00 | | | 0.0 | N/A |
 Register for FREE access to the latest Amag Pharmaceuticals company information and fundamental data for other USA Common Stock companies. More than 100 separate statistics including assets turnover and non-current assets. |
Latest Amag Pharmaceuticals Stock Trade| Type | Size | Price | Date | Tr.Time | Units | | | 100 | 13.12 | 05/21/2012 | 10:27AM | USD |
|
|
| |